Skip to main content

Table 4 Serum ESM-1 concentration change and reduction rate before and after drug change

From: Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease

 

ESM-1 (pg/mL)

Reduction rate (%)

Before

After

Median (IQR)

224.2 (154.9, 502.1)

174.1 (90.45, 320)

22.3

Case 1

93.66357412

44.32312565

52.7

Case 2

216.0889026

174.1042404

19.4

Case 3

702.4123208

420.973109

40

Case 4

301.8416083

218.9565517

27.5

Case 5

224.2057542

136.5815375

39.1

  1. Abbreviations: ESM-1 Endothelial cell-specific molecule-1, IQR Interquartile range
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us